The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index; none of the 2 sources its claims cite is checked for support yet.
BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.
Open accessAbstract
The BCL2 protooncogene encodes an inner mitochondrial membrane protein that blocks programmed cell death. BCL2 was isolated from the chromosomal breakpoint of follicular B-cell lymphoma. Transgenic mice that overexpress BCL2 display extended survival of resting B cells. In this study we use a monospecific anti-human BCL2 antibody to define the distribution of BCL2 protein within organized tissues. BCL2 is restricted within germinal centers to the follicular mantle and to portions of the light zone implicated in the selection and maintenance of plasma cells and memory B cells. BCL2 is present in the surviving T cells in the thymic medulla. All hematopoietic lineages that derive from a renewing stem cell also display BCL2. A limited number of nonlymphoid tissues demonstrate BCL2 and can be grouped as (i) glandular epithelium in which hormones or growth factors regulate hyperplasia and involution, (ii) complex differentiating epithelium such as skin and intestine characterized by long-lived stem cells, and (iii) long-lived postmitotic cells such as neurons. Within these tissues that demonstrate apoptotic cell turnover, BCL2 is often topographically restricted to long-lived or proliferating cell zones. BCL2's function as an antidote to apoptosis may confer longevity to progenitor and effector cells in these tissues.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Using a monospecific anti-human BCL2 antibody, the authors map BCL2 protein across organized tissues and find it topographically restricted to long-lived or proliferating zones in tissues with apoptotic turnover. BCL2 is present in selected lymphoid, hematopoietic, glandular epithelial, complex epithelial, and postmitotic neuronal compartments.
Key findings
- Within germinal centers, BCL2 is restricted to the follicular mantle and portions of the light zone implicated in selection and maintenance of plasma cells and memory B cells.
- BCL2 is present in surviving T cells in the thymic medulla and in all hematopoietic lineages derived from a renewing stem cell.
- A limited set of nonlymphoid tissues shows BCL2: glandular epithelium regulated by hormones/growth factors, complex differentiating epithelium such as skin and intestine with long-lived stem cells, and long-lived postmitotic cells such as neurons.
- In tissues with apoptotic cell turnover, BCL2 is often topographically restricted to long-lived or proliferating cell zones; the authors suggest BCL2 may confer longevity to progenitor and effector cells.
Methods
- The study uses a monospecific anti-human BCL2 antibody to define BCL2 protein distribution within organized tissues.
- The provided text does not report sample sizes, tissue sources, staining protocols, or quantitative analysis details.
Limitations
- The paper’s abstract does not state limitations.
- Evident from the provided text: only the abstract and reference list are available, so sample composition, antibody specificity controls, quantification, and full results cannot be assessed. No quantitative values are reported in the provided text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Own interpretation · 4 Own result · 2 No full text of the sources · 1 No basis given
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“All hematopoietic lineages that derive from a renewing stem cell also display BCL2.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BCL2 is present in the surviving T cells in the thymic medulla.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A limited number of nonlymphoid tissues demonstrate BCL2”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BCL2 is restricted within germinal centers to the follicular mantle and to portions of the light zone implicated in the selection and maintenance of plasma cells and memory B cells.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Within these tissues that demonstrate apoptotic cell turnover, BCL2 is often topographically restricted to long-lived or proliferating cell zones.”
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“glandular epithelium in which hormones or growth factors regulate hyperplasia and involution”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“long-lived postmitotic cells such as neurons”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
In the paper
“Transgenic mice that overexpress BCL2 display extended survival of resting B cells.”
What the sources say
- Not checked — no full text of the sourcecites McDonnell et al., 1989 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“complex differentiating epithelium such as skin and intestine characterized by long-lived stem cells”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BCL2's function as an antidote to apoptosis may confer longevity to progenitor and effector cells in these tissues.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
- It may state two separate claims as one. 1
In the paper
“The BCL2 protooncogene encodes an inner mitochondrial membrane protein that blocks programmed cell death.”
What the sources say
- Not checked — no full text of the sourcecites Hockenbery et al., 1990 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
The anti-human BCL2 antibody used in this study is monospecific for BCL2.
“we use a monospecific anti-human BCL2 antibody”
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,673
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Self-citationBcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D., Cory, S., & Adams, J. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,355
Cheng, H., & Leblond, C. P. (1974) · American Journal of Anatomy · doi:10.1002/aja.1001410407 · Cited by 1,737
Savill, J. S., Wyllie, A. H., Henson, J. E., Walport, M. J., Henson, P. M., & Haslett, C. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113970 · Cited by 1,536
Cohen, J., & Duke, R. C. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.1.38 · Cited by 1,406
Regressive Events in Neurogenesis
Cowan, W. M., Fawcett, J. W., O'Leary, D. D. M., & Stanfield, B. B. (1984) · Science · doi:10.1126/science.6474175 · Cited by 1,316
McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P., & Korsmeyer, S. J. (1989) · Cell · doi:10.1016/0092-8674(89)90174-8 · Cited by 1,213
Self-citationCleary, M. L., Smith, S. D., & Sklar, J. (1986) · Cell · doi:10.1016/0092-8674(86)90362-4 · Cited by 1,212
Bakhshi, A., Jensen, J. P., Goldman, P., Wright, J. J., McBride, O. W., Epstein, A. L., & Korsmeyer, S. J. (1985) · Cell · doi:10.1016/s0092-8674(85)80070-2 · Cited by 1,177
Self-citation
Cited by
Sorted by citations
Items 301–400 of 1,244
Tiberio, R., Marconi, A., Fila, C., Fumelli, C., Pignatti, M., Krajewski, S., Giannetti, A., Reed, J. C., & Pincelli, C. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03040-5 · Cited by 99
Bcl-x rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center
Tuscano, J. M., Druey, K. M., Riva, A., et al. (1996) · Blood · doi:10.1182/blood.v88.4.1359.bloodjournal8841359 · Cited by 97
Bcl-2 Expression and p38MAPK Activity in Cells Infected with Influenza A Virus
Nencioni, L., Chiara, G. D., Sgarbanti, R., Amatore, D., Aquilano, K., Marcocci, M. E., Serafino, A., Torcia, M. G., Cozzolino, F., Ciriolo, M. R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900146200 · Cited by 96
The involvement of oncogenes and tumor suppressor genes in the control of apoptosis
Oren, M. (1992) · Cancer and Metastasis Reviews · doi:10.1007/bf00048060 · Cited by 96
“A comprehensive study of bcl-2 expression in human tissues revealed that the protein is restricted to tissues which are known to contain cells undergoing apoptosis [25].”
BackgroundLong, R. M., Morrissey, C. M., Fitzpatrick, J. M., & Watson, R. W. G. (2004) · Clinical Science · doi:10.1042/cs20040241 · Cited by 104
Alagoz, T., Buller, R. E., Anderson, B., Terrell, K. L., Squatrito, R. C., Niemann, T. H., Tatman, D. J., & JEBSON, P. J. R. (1995) · Cancer · doi:10.1002/1097-0142(19950501)75:9 · Cited by 29
Plettenberg, A., Ballaun, C., Pammer, J., Mildner, M., Strunk, D., Weninger, W., & Tschachler, E. (1995) · Europe PMC (PubMed Central) · Cited by 95
Yang, G., Zhang, Z., Liao, J., Seril, D., Wang, L., Goldstein, S., & Yang, C. S. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970904)72:5 · Cited by 38
Benito, A., Grillot, D., Núñez, G., & Fernández-Luna, J. L. (1995) · Europe PMC (PubMed Central) · Cited by 94
Radhiga, T., Rajamanickam, C., Sundaresan, A., et al. (2012) · Biochimie · doi:10.1016/j.biochi.2012.01.015 · Cited by 93
Thatte, U. M., & Dahanukar, S. A. (1997) · Drugs · doi:10.2165/00003495-199754040-00002 · Cited by 95
Bcl‐2 expression is associated with lymph node metastasis in human ductal breast carcinoma
Sierra, À., Lloveras, B., Castellsagué, X., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600108 · Cited by 93
Bcl-2 Protein as a Marker of Neuronal Immaturity in Postnatal Primate Brain
Bernier, P. J., & Parent, A. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-07-02486.1998 · Cited by 92
“Clone 124 antibody recognized a single major band migrating at ;26 kDa, which is consistent with the molecular weight of Bcl-2 protein (Pezzella et al., 1990; Hockenbery et al., 1991; Haldar et al., 1994) (Fig.”
BackgroundDummer, R., Michie, S. A., Kell, D., Gould, J. W., Haeffner, A. C., Smoller, B. R., Warnke, R. A., & Wood, G. S. (1995) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.1995.tb00733.x · Cited by 91
Bcl-2 Is a Key Factor for Cardiac Fibroblast Resistance to Programmed Cell Death
Mayorga, M. E., Bahí, N., Ballester, M., Comella, J. X., & Sanchı́s, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404616200 · Cited by 91
Krajewski, S., Gascoyne, R. D., Zapata, J. M., et al. (1997) · Blood · doi:10.1182/blood.v89.10.3817 · Cited by 91
Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.
Sinicrope, F. A., Hart, J. A. L., Hsu, H. A., Lemoine, M., Michelassi, F., & Stephens, L. C. (1999) · PubMed · Cited by 90
Retinoids and the control of growth/death decisions in human neuroblastoma cell lines
Melino, G., Thiele, C. J., Knight, R. A., & Piacentini, M. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005733430435 · Cited by 90
Gallo, O., Boddi, V., Calzolari, A., et al. (1996) · PubMed · Cited by 89
Cell division versus cell death: A functional model of multistep neoplasia
McDonnell, T. J. (1993) · Molecular Carcinogenesis · doi:10.1002/mc.2940080402 · Cited by 89
Fotedar, R., Diederich, L., & Fotedar, A. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5873-6_15 · Cited by 91
Taylor, J. K., Zhang, Q. Q., Monia, B. P., Marcusson, E. G., & Dean, N. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202836 · Cited by 87
“Immunohistochemistry has been used to identify Bcl-2 and Bcl-xL expression patterns in normal skin in vivo (Hockenbery et al., 1991; Krajewski et al., 1994).”
BackgroundMethodApoptosis Is Inhibited Early in the Dysplasia-Carcinoma Sequence of Barrett Esophagus
Katada, N. (1997) · Archives of Surgery · doi:10.1001/archsurg.1997.01430310042007 · Cited by 89
Two Pathways for Induction of Apoptosis by Ultraviolet Radiation in Cultured Human Keratinocytes
Gniadecki, R., Hansen, M., & Wulf, H. C. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12319216 · Cited by 90
Dluzen, D. F., Li, G., Tacelosky, D. M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.207639 · Cited by 88
Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer
Linjawi, A., Kontogiannea, M., Halwani, F., et al. (2003) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2003.08.008 · Cited by 88
WOOD, K. A., & Youle, R. J. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21829.x · Cited by 88
Direct involvement of p53 in programmed cell death of oligodendrocytes.
Eizenberg, O., Faber‐Elman, A., Gottlieb, E., Oren, M., Rotter, V., & Schwartz, M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07097.x · Cited by 87
bcl-2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas
Smoller, B. R., van de Rijn, M., LeBrun, D. P., et al. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb08453.x · Cited by 87
Zheng, X., Fu, D., Cheng, J., Tang, R., Chu, M., Chu, P., Wang, T., & Yin, S. (2021) · Aquaculture · doi:10.1016/j.aquaculture.2021.736945 · Cited by 87
In vitro models of prostate apoptosis: Clusterin as an antiapoptotic mediator
Lee, C., Janulis, L., Ilio, K. Y., Shah, A., Park, I., Kim, S., Cryns, V. L., Pins, M., & Bergan, R. C. (2000) · The Prostate · doi:10.1002/1097-0045(2000)45:9+ · Cited by 13
Ioffe, O. B., Papadimitriou, J. C., & Drachenberg, C. B. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90429-4 · Cited by 86
Patterns of cell death: the significance of apoptosis for dermatology
Paus, R., Rosenbach, T., Haas, N., et al. (1993) · Experimental Dermatology · doi:10.1111/j.1600-0625.1993.tb00192.x · Cited by 85
Mancuso, T., Mezzelani, A., Riva, C., Fabbri, A., Bo, L. D., Sampietro, G., Perego, P., Casali, P. G., Zunino, F., Sozzi, G., et al. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780085 · Cited by 83
“Nevertheless, with the studies on adult and embryonic normal human tissues (Hockenbery et al, 1991; Lu et al, 1993b) and comparative studies of other soft tissues spindle cell sarcomas (Hirakawa et al, 1996; Suster et al, 1998), bcl-2 [over]expression seems to be both a constitutive alteration…”
BackgroundResultBofill, M., Gombert, W. M., Borthwick, N., Akbar, A. N., McLaughlin, J., Lee, C. A., Johnson, M. A., Pinching, A. J., & Janossy, G. (1995) · Europe PMC (PubMed Central) · Cited by 84
Bcl-2 interaction with the inositol 1,4,5-trisphosphate receptor: Role in Ca2+ signaling and disease
Distelhorst, C., & Bootman, M. D. (2011) · Cell Calcium · doi:10.1016/j.ceca.2011.05.011 · Cited by 83
Immunohistochemical evaluation of bcl-2 oncoprotein in oral dysplasia and carcinoma
Singh, B. B., Chandler, F. W., Whitaker, S. B., et al. (1998) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/s1079-2104(98)90037-3 · Cited by 83
Hormonal regulation of physiological cell turnover and apoptosis
Medh, R. D., & Thompson, E. B. (2000) · Cell and Tissue Research · doi:10.1007/s004419900159 · Cited by 85
“It has been demonstrated that epithelial cells in the colonic lumen express the proapoptotic Bax protein while those in the crypts are rich in Bcl-2 (Hockenbery et al. 1991; Krajewski et al. 1994).”
BackgroundInfluentialLee, W., Su, W., Lin, P., Guo, H., Chang, T.-W., & Chen, H. H. W. (2004) · Oncology · doi:10.1159/000079496 · Cited by 83
“Gene expression of bcl-2, mutant p53, and survivin, for example, inhibits apoptosis [”
BackgroundNielsen, B. S., Timshel, S., Kjeldsen, L., Sehested, M., Pyke, C., Borregaard, N., & Danø, K. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960103)65:1 · Cited by 173
Troost, D., Aten, J., Morsink, F. H. M., et al. (1995) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1995.tb01096.x · Cited by 83
Latil, A., Jc, B., Cussenot, O., et al. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870110208 · Cited by 83
Srivastava, N., Manvati, S., Srivastava, A., Pal, R., Ponnusamy, K., Chattopadhyay, S., Gochhait, S., Dua, R., & Bamezai, R. N. K. (2011) · Breast Cancer Research · doi:10.1186/bcr2861 · Cited by 83
“We propose that while downregulation of H2AX results in impaired DNA repair, channeling the cells into the apoptotic pathway, downregulated BCL-2, encoding an integral outer mitochondrial membrane protein and known to block the apoptotic death in a variety of cell systems [40], could contribute further to apoptotic ce…”
BackgroundProgrammed Cell Death and Cell Transformation in Craniofacial Development
Shuler, C. F. (1995) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411950060030301 · Cited by 80
Szondy, Z., Reichert, U., & Fésüs, L. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400313 · Cited by 81
“In these cells bcl-2, an apoptosis inhibitory protein (Hockenbery et al, 1991) becomes upregulated and protects cells against death (Sentman et al, 1991; Szondy, 1997).”
BackgroundFactors for progression of periodontal diseases
Ellis, S. D., Tucci, M. A., Serio, F. G., & Johnson, R. B. (1998) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1998.tb01923.x · Cited by 82
Apoptosis: Pathophysiology of Programmed Cell Death
Bosman, F. T., Visser, B. C., & Oeveren, J. V. (1996) · Pathology - Research and Practice · doi:10.1016/s0344-0338(96)80089-6 · Cited by 79
Expression of Fas antigen and Bcl-2 in human glomerulonephritis
Takemura, T., Murakami, K., Miyazato, H., et al. (1995) · Kidney International · doi:10.1038/ki.1995.487 · Cited by 82
Apoptosis and gastrointestinal pharmacology
Pritchard, D. M., & Watson, A. J. M. (1996) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00102-7 · Cited by 82
Target to apoptosis: A hopeful weapon for prostate cancer
Tang, D. G., & Porter, A. T. (1997) · The Prostate · doi:10.1002/(sici)1097-0045(19970901)32:4 · Cited by 191
Camisasca, D. R., Honorato, J., Bernardo, V. G., et al. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2008.05.021 · Cited by 81
Weber-Nordt, R., Henschler, R., SchOTT, E. H., Wehinger, J., Behringer, D. M., Mertelsmann, R. H., & Finke, J. (1996) · Blood · doi:10.1182/blood.v88.7.2549.bloodjournal8872549 · Cited by 81
Epstein-Barr Virus Infects and Induces Apoptosis in Human Neutrophils
Larochelle, B., Flamand, L., Gourde, P., et al. (1998) · Blood · doi:10.1182/blood.v92.1.291.413k34_291_299 · Cited by 81
Nishikawa, A., & Hayashi, H. (1995) · Differentiation · doi:10.1046/j.1432-0436.1995.5940207.x · Cited by 81
Rapid Development of Affinity Matured Monoclonal Antibodies Using RIMMS
Kilpatrick, K. E., Wring, S. A., Walker, D. H., et al. (1997) · Hybridoma · doi:10.1089/hyb.1997.16.381 · Cited by 81
Akpek, E. K., Maca, S. M., Christen, W. G., et al. (1999) · Ophthalmology · doi:10.1016/s0161-6420(99)90528-6 · Cited by 81
Häussler, O., Epstein, J. I., Amin, M. B., Heitz, P. U., & Hailemariam, S. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90226-5 · Cited by 80
Overexpression of Bcl-2 or Bcl-XL transgenes and photoreceptor degeneration.
Joseph, R. M., & Li, T. (1996) · PubMed · Cited by 81
Role of bcl-2 in the Development of Lymphoid Cells From the Hematopoietic Stem Cell
Matsuzaki, Y., Nakayama, K., Nakayama, K., Tomita, T., 磯田魅卯, Loh, D. Y., & Nakauchi, H. (1997) · Blood · doi:10.1182/blood.v89.3.853 · Cited by 81
Apoptosis: Programmed Cell Death
Kuan, N.-K. (1998) · Archives of Surgery · doi:10.1001/archsurg.133.7.773 · Cited by 79
“Two opposing mechanisms that maintain homeostatic control of apoptosis are the Fas ligand(8) and the protein expressed by the Bcl-2 gene.(9) The Fas ligand promotes cell death by binding to Fas, a cell membrane receptor, initiating a series of intracellular events leading to apoptosis.”
BackgroundLoro, L. L., Vintermyr, O. K., Liavaag, P. G., et al. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90229-0 · Cited by 80
Arscott, P. L., & Baker, J. R. (1998) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1998.4526 · Cited by 80
Differential expression of the bcl-2 oncogene in human basal cell carcinoma
CROWSON, A. N., MAGRO, C. M. J., Kadin, M. E., & Stranc, M. F. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90108-2 · Cited by 79
Dispersyn, G. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00096-6 · Cited by 81
Arriola, E. L., Rodríguez-López, A. M., Hickman, J. A., & Chresta, C. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202420 · Cited by 79
“This may be related to the origin of these tumours, from immature cells of the testis, which similarly do not express Bcl-2 (Hockenbery et al., 1991; Lu et al., 1993).”
BackgroundReactive Oxygen Species and Their Contribution to Pathology in Down Syndrome
de Haan, J. B., Wolvetang, E. J., Cristiano, F., Iannello, R. C., Bladier, C., Kelner, M. J., & Kola, I. (1996) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60992-8 · Cited by 81
In Situ Detection of Apoptosis at Sites of Chronic Bacterially Induced Inflammation in Human Gingiva
Tonetti, M. S., Cortellini, D., & Lang, N. P. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5190-5195.1998 · Cited by 78
Aiello, A., Delia, D., Borrello, M. G., et al. (1992) · Cytometry · doi:10.1002/cyto.990130509 · Cited by 78
Lu, Q., Hanby, A. M., Hajibagheri, M. A. N., Gschmeissner, S. E., Lu, P., Taylor‐Papadimitriou, J., Krajewski, S., Reed, J. C., & Wright, N. A. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.2.363 · Cited by 78
Gupta, P., Niehans, G. A., LeRoy, S., Gupta, K., Morrison, V., Schultz, C. L., Knapp, D., & Kratzke, R. (1999) · Leukemia · doi:10.1038/sj.leu.2401233 · Cited by 78
Finke, J., Slanina, J., Lange, W., et al. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.9.1668 · Cited by 78
King, B. E., Chen, C. G., Locker, J. D., et al. (2000) · Modern Pathology · doi:10.1038/modpathol.3880226 · Cited by 77
“Bcl-2, an antiapoptotic protein, is present in many normal B and T cells; however, most normal FCC lack bcl-2 protein even though they contain abundant bcl-2 mRNA (14, 15, 21, 88, 89).”
BackgroundImmunoreactivity for p53 protein in malignant mesothelioma and non‐neoplastic mesothelium
Ramael, M., Lemmens, G., Eerdekens, C., Buysse, C. M. P., Deblier, I., Jacobs, W., & Marck, E. V. (1992) · The Journal of Pathology · doi:10.1002/path.1711680406 · Cited by 77
bcl-2 protein expression in tumors of the central nervous system
Nakasu, S., Nakasu, Y., Nioka, H., et al. (1994) · Acta Neuropathologica · doi:10.1007/bf00296488 · Cited by 77
Lee, E. H., Cho, S. Y., Kim, S. J., Shin, E. S., Chang, H. K., Kim, D. H., Yeom, M. H., Woe, K. S., Lee, J., Sim, Y. C., et al. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12425.x · Cited by 76
Lapointe, J., Fournier, A., Richard, V., & Labrie, C. (1999) · Endocrinology · doi:10.1210/endo.140.1.6410 · Cited by 76
Pathogenesis of ECL cell tumors in humans.
Bordi, C., D’Adda, T., Azzoni, C., et al. (1999) · PubMed · Cited by 75
The Pharmacology of T Cell Apoptosis
Kroemer, G. (1995) · Advances in immunology · doi:10.1016/s0065-2776(08)60621-5 · Cited by 75
Detection of BCL2 Rearrangements in Follicular Lymphoma
Aster, J. C., & Longtine, J. A. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64897-3 · Cited by 75
Shin, D. H., Lee, E., Kim, J.-W., Kwon, B. S., Jung, M. K., Jee, Y. H., Kim, J., Bae, S.-R., & Chang, Y. P. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.09.070 · Cited by 75
Dopamine-Induced Apoptosis Is Inhibited in PC12 Cells Expressing Bcl-2
Offen, D., Ziv, I., Panet, H., Wasserman, L., Stein, R., Melamed, E., & Barzilai, A. (1997) · Cellular and Molecular Neurobiology · doi:10.1023/a:1026390201168 · Cited by 75
Tao, W., Teh, S.-J., Melhado, I. G., et al. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.1.145 · Cited by 75
Self-citationLiu, J., Li, S., Wang, Q., Feng, Y., Xing, H., Yang, X., Guo, Y., Guo, Y., Sun, H., Liu, X., et al. (2024) · Blood · doi:10.1182/blood.2023019706 · Cited by 76
Expression of SGLT1, Bcl-2 and p53 in Primary Pancreatic Cancer Related to Survival
Casneuf, V. F., Fonteyne, P., Damme, N. V., Demetter, P., Pauwels, P., de Hemptinne, B., Vos, M. D., de Wiele, C. V., & Peeters, M. (2008) · Cancer Investigation · doi:10.1080/07357900801956363 · Cited by 75
Warraich, R. S., Noutsias, M., Kasac, I., Seeberg, B., Dunn, M. J., Schultheiß, H., Yacoub, M. H., & Kühl, U. (2002) · American Heart Journal · doi:10.1067/mhj.2002.124406 · Cited by 74
Keratinocytes Become Terminally Differentiated in a Process Involving Programmed Cell Death
Maruoka, Y., Harada, H., Mitsuyasu, T., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7405 · Cited by 74
Mertens, H. J. M. M., Heineman, M. J., & Evers, J. L. H. (2002) · Gynecologic and Obstetric Investigation · doi:10.1159/000064569 · Cited by 73
Hussein, M. R., Al‐Badaiwy, Z. H., & Guirguis, M. N. (2004) · Journal of Cutaneous Pathology · doi:10.1111/j.0303-6987.2004.00244.x · Cited by 72
Glick, S. H., Howell, L. P., & White, R. D. (1996) · PubMed · Cited by 72
Differential protective effects of Bcl-xLand Bcl-2 on apoptotic liver injury in transgenic mice
Coste, A. D. L., Fabrè, M., McDonell, N., Porteu, A., Gilgenkrantz, H., Perret, C., Kahn, A., & Mignon, A. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.277.3.g702 · Cited by 71
Bcl‐2 protooncogene expression in cervical carcinoma cell lines containing inactive p53
Liang, X. H., Mungal, S., Ayscue, A. H., Meissner, J. D., Wodnicki, P., Hockenbery, D. M., Lockett, S., & Herman, B. A. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240570316 · Cited by 72
Self-citationbcl-2 and p53 protein expression in non-small cell lung cancers: Correlation with survival time
Ohsaki, Y., Toyoshima, E., Fujiuchi, S., Matsui, H., Hirata, S., Miyokawa, N., Kubo, Y., & Kikuchi, K. (1996) · Lung Cancer · doi:10.1016/s0169-5002(97)89521-9 · Cited by 73
Kaposi's sarcoma tumor cells preferentially express Bcl-xL.
Foreman, K. E., Wrone-Smith, T., Boise, L., Thompson, C. B., Polverini, P. J., Simonian, P. L., Núñez, G., & Nickoloff, B. J. (1996) · Europe PMC (PubMed Central) · Cited by 72
Matsushita, K., Matsuyama, T., Kitagawa, K., et al. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00391-6 · Cited by 72
Han, F., Liu, W., JIANG, X. H., Shi, X. A., Yin, L., Ao, L., Cui, Z., Li, Y., Huang, C., Cao, J., et al. (2014) · Oncogene · doi:10.1038/onc.2014.370 · Cited by 71
Sandra, F., Nakamura, N., Mitsuyasu, T., et al. (2001) · Histopathology · doi:10.1046/j.1365-2559.2001.01138.x · Cited by 71
“Immunoreactivity for the bcl-2 product is present mainly in cell populations which are long lived, and/or with high proliferation ability.(14) In this study, bcl-2 was Table 1.”
BackgroundScopa, C. D., Vagianos, C., Kardamakis, D. M., et al. (2001) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200112000-00007 · Cited by 71
Tamaru, Y., Miyawaki, T., Iwaï, K., et al. (1993) · Blood · doi:10.1182/blood.v82.2.521.521 · Cited by 71
Mishima, K., Horiuchi, K., Kojya, S., Takahashi, H., Ohsawa, M., & Aozasa, K. (1994) · Cancer · doi:10.1002/1097-0142(19940615)73:12 · Cited by 29
Hepatitis B virus X protein induces apoptosis in hepatoma cells through inhibiting Bcl-xL expression
Miao, J., Chen, G. G., Chun, S.-Y., & Lai, P. B. S. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.05.014 · Cited by 68
“In vivo, previous studies using immunohistochemistry have also revealed that Bcl-2 is not generally expressed in human hepatocytes [44,45].”
Background
Metadata
- Authors
- Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., & Korsmeyer, S. J.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1991-08-15
- Volume
- 88
- Issue
- 16
- Pages
- 6961-6965
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC52213
- OpenAlex
- W1970629830
- Semantic Scholar
- d825dc162ad208c572711f59c9aa1c7974e89492
- Cited by
- 1,252
- References
- 40
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 9 · 2022: 4 · 2021: 5 · 2020: 10 · 2019: 9 · 2018: 9 · 2017: 9 · 2016: 7 · 2015: 10 · 2014: 15 · 2013: 10 · 2012: 12
- FWCI
- 26.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- Bcl-2, apoptosis, germinal center, light zone, plasma cells, memory B cells, thymic medulla, hematopoietic stem cells, tissue distribution, epithelial stem cells, follicular B-cell lymphoma, transgenic mice
- MeSH terms
- Adult, Bone Marrow, Breast, Cell Survival, Digestive System, Female, Humans, Immunoenzyme Techniques, Male, Neurons, Pancreas, Prostate, Protein-Tyrosine Kinases, Proto-Oncogene Proteins, Proto-Oncogenes, Skin, Thymus Gland, Palatine Tonsil, Proto-Oncogene Proteins c-bcl-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
